Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second cause of cancer-related death. Search for genes/proteins whose expression can discriminate between normal and neoplastic liver is fundamental for diagnostic, prognostic and therapeutic purposes. Currently, the most used in vitro hepatocyte models to study molecular alterations underlying transformation include primary hepatocytes and transformed cell lines. However, each of these models presents limitations. Here we describe the isolation and characterization of two rat hepatocyte cell lines as tools to study liver carcinogenesis. Long-term stable cell lines were obtained from a HCC-bearing rat exposed to the Resistant-Hepatocyte protocol (RH cells) and ...
Metabolic alterations in hepatocellular carcinoma (HCC) are fundamental for the development of diagn...
Dysplastic hepatocytes (DH) represent altered hepatocytes with potential for malignant transformatio...
Non-tumorous liver tissue removed during surgery to resect hepatocellular carcinoma (HCC) is potenti...
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second cause of can...
Introduction: There has been a heavy reliance on the use of hepatoma cell lines to study the pathwa...
Although the expression of the stem/progenitor cell marker cytokeratin-19 (CK-19) has been associate...
Background: Although metabolism is profoundly altered in human liver cancer, the extent to which exp...
Immortalized hepatic stellate cells (HSCs) established from mouse, rat, and humans are valuable in v...
[[abstract]]Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality. Cancer ...
BACKGROUND/AIMS: Oval cells (OCs), putative hepatic stem cells, may give rise to liver cancers. We d...
Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical subgroups. A pr...
<div><p>Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis worldwide and the mole...
The increasing demand and hampered use of primary human hepatocytes for research purposes have urged...
Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis worldwide and the molecular me...
BACKGROUND: Because few definitive markers are available for hepatic cancer stem cells (HCSCs), base...
Metabolic alterations in hepatocellular carcinoma (HCC) are fundamental for the development of diagn...
Dysplastic hepatocytes (DH) represent altered hepatocytes with potential for malignant transformatio...
Non-tumorous liver tissue removed during surgery to resect hepatocellular carcinoma (HCC) is potenti...
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the second cause of can...
Introduction: There has been a heavy reliance on the use of hepatoma cell lines to study the pathwa...
Although the expression of the stem/progenitor cell marker cytokeratin-19 (CK-19) has been associate...
Background: Although metabolism is profoundly altered in human liver cancer, the extent to which exp...
Immortalized hepatic stellate cells (HSCs) established from mouse, rat, and humans are valuable in v...
[[abstract]]Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality. Cancer ...
BACKGROUND/AIMS: Oval cells (OCs), putative hepatic stem cells, may give rise to liver cancers. We d...
Human hepatocellular carcinoma (HCC) is a heterogeneous disease of distinct clinical subgroups. A pr...
<div><p>Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis worldwide and the mole...
The increasing demand and hampered use of primary human hepatocytes for research purposes have urged...
Hepatocellular carcinoma (HCC) is a common cancer with poor prognosis worldwide and the molecular me...
BACKGROUND: Because few definitive markers are available for hepatic cancer stem cells (HCSCs), base...
Metabolic alterations in hepatocellular carcinoma (HCC) are fundamental for the development of diagn...
Dysplastic hepatocytes (DH) represent altered hepatocytes with potential for malignant transformatio...
Non-tumorous liver tissue removed during surgery to resect hepatocellular carcinoma (HCC) is potenti...